US equities |
NVDA $240.62 ▲+0.72% SPCX $173.66 ▲+1.50% MU $1,064.83 ▲+0.08% MRVL $283.66 ▲+4.58% AMD $656.00 ▲+3.84% INTC $114.38 ▼-1.56% SNDK $1,669.81 ▼-2.02% AVGO $377.65 ▲+4.18%
FinancialContent

Latest News about SGLT2

Recent news which mentions SGLT2

2023 HFSA CME Symposium - Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure: From Evidence to Clinical Practice
Tags Event SGLT2 #HFSA2023
From PRLog
2023 ANNA CE Symposium- Newer Therapies to Optimize Outcomes in Patients with Chronic Kidney Disease
Tags Hazlet Event RAASi
From PRLog
CME Symposium- Bridging the Gap Between Evidence and Clinical Practice: Improving Outcomes with #SGLT2Inhibitors in Patients with #HeartFailure
Tickers CME
Tags Education Cme Event
From PRLog